Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2015 Sep 22.
Published in final edited form as: Mol Pharm. 2015 Jun 1;12(7):2558. doi: 10.1021/acs.molpharmaceut.5b00366

Retraction

PMCID: PMC4578222  NIHMSID: NIHMS723015  PMID: 26027478

Retraction of “Hydrophilic Prodrug Approach for Reduced Pigment Binding and Enhanced Transscleral Retinal Delivery of Celecoxib”

Pradip Malik, Rajendra S. Kadam, Narayan P. S. Cheruvu, and Uday B. Kompella*

The authors retract the article “Hydrophilic Prodrug Approach for Reduced Pigment Binding and Enhanced Transscleral Retinal Delivery of Celecoxib”, Mol. Pharmaceutics 2012, 9 (3), 605–614, following a scientific misconduct investigation by the University of Colorado Denver Anschutz Medical Campus, which concluded that the LC–MS data supporting Figures 3, 5, 6, and 7 were falsified by Rajendra Kadam to reduce variability in measurements, to produce smooth kinetics, or to create statistical differences. The fabrication of data related to these figures raises questions about the conclusions within the paper.

RESOURCES